ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
US filing for ViiV’s two-drug, single pill HIV treatment
pharmatimes
November 01, 2018ViiV Healthcare has submitted a New Drug Application to the US Food and Drug Administration seeking permission to market a single-tablet, two-drug regimen of dolutegravir and lamivudine for the treatment of HIV...
Pharma Sources Insight January 2025
